Mozhi Wang

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

First Hospital of China Medical University(Current)

China Medical University

Mozhi Wang is an author at First Hospital of China Medical University specializing in cancer immunology, molecular tumor profiling, and bioinformatics.

Publications per year

2023–2025

Publications

Efficacy, safety and exploratory analysis of neoadjuvant tislelizumab (a PD-1 inhibitor) plus nab-paclitaxel followed by epirubicin/cyclophosphamide for triple-negative breast cancer: a phase 2 TREND trial

Qiang Zhang, Mozhi Wang, Yumeng Li et al. · Signal Transduction and Targeted Therapy · 2025 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17

PROS1, a clinical prognostic biomarker and tumor suppressor, is associated with immune cell infiltration in breast cancer: A bioinformatics analysis combined with experimental verification

Tianyi He, Xiangyu Sun, Chen Wu et al. · Cellular Signalling · 2023 · 12 citations

Medicine, Bioinformatics, Oncology +17

1–2 of 2